BioSpace News Archive

Can more personalized cancer care lead to better outcomes and improved patient satisfaction among cancer patients? Cindi Slater , MD, FACR, senior vice president of Medical Affairs for national expert medical guidance company ConsumerMedical, will give a presentation addressing that topic at the Pittsburgh Business Group on Health (PBG

Proceeds to support the advancement of lead candidate through the final stages of clinical development for recurrent C. difficile infection, and the advancement into the clinic of programs for autism spectrum disorder and chronic hepatitis B SOMERVILLE, Mass.--( BUSINESS WIRE )-- Finch Therapeutics Group, Inc. (“Finch”), a clinical-stage microbiome drug development company, announced today a $90 million Series D financing. New investors in the roun

Papyrus Therapeutics, Inc. (“Papyrus” or the “Company”), an emerging biopharma company developing novel extracellular tumor suppressor therapies for the treatment of cancer and Oxford Biomedica plc (LSE:OXB or the “Group”), a leading gene and cell therapy group, announced today the signing of a research collaboration agreement. The collaboration includes the assessment of the impact and therapeutic benefit of Papyr

Mydecine Innovations Group, Inc., is pleased to announce that its wholly-owned subsidiary, Mindleap Health, has implemented a comprehensive information security rollout of next-generation cyber-security solutions to meet HIPAA compliance standards.

Tris Pharma, Inc. (Tris), a specialty pharmaceutical company with a robust portfolio of FDA-approved products for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, announced today the launch of a redesigned website for healthcare professionals (HCPs). This newly redesigned

GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced that the company will participate in the Morgan Stanley Global Healthcare Conference on September 18 at 8:00 a.m. (ET).

Avadel Pharmaceuticals plc (Nasdaq: AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place September 21 – 23, 2020.

XWPharma (formerly XW Laboratories), a biopharmaceutical company dedicated to the discovery and development of therapeutics that apply novel platform chemistry to time-regulated neurobiology, today announced it completed a $40 million Series C financing

Belong.Life (Belong), a developer of social and professional networks for managing and navigating treatments, and the creator of the world’s largest social network for cancer patients has published a study showing that almost half of cancer patients receiving immunotherapy and suffering from Financial Toxicity (FT) were not aware of the possible development of FT prior to treatment.

- Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT) (TSX: NEPT), a diversified and fully integrated health and wellness company focused on natural, plant-based, sustainable, and purpose-driven lifestyle brands, announced that Michael Cammarata , its President and Chief Executive Officer, w